ArticleScientific reports2025
Determinants of diabetic ketoacidosis among adults with diabetes mellitus at the Ambo town Hospitals, Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic ketoacidosis (DKA) is a life-threatening hyperglycemic emergency with high morbidity and mortality in diabetes. This study explored determinants of diabetic ketoacidosis among adult diabetic patients in Ambo Town, Ethiopia. An unmatched case-control study was conducted from February 1 to March 30, 2024, involving 78 DKA cases and 230 controls (patients with diabetes mellitus and without DKA). Data were collected through structured questionnaires and chart reviews. Quality assurance measures included pretesting, data collector training, and supervision. Data were analyzed using SPSS version 25, with binary logistic regression identifying significant determinants, considering p < 0.05 as significant. The mean age of participants was 45.87 years (± 17.12 SD). Statistically significant determinants of DKA included being a type 1 diabetic [AOR 3.5; 95% CI 1.54-7.96], presence of comorbidities [AOR 4.82; 95% CI 2.03-11.42], irregular attendance at diabetic clinic appointments [AOR 6.14; 95% CI 2.25-14.7], discontinuation of prescribed medications [AOR 3.07; 95% CI 1.34-7.04], lack of health insurance [AOR 5.00; 95% CI 2.22-11.26] and other diabetes-related complications [AOR 4.25; 95% CI 1.59-11.3]. Therefore, Interventions should target follow-up care, medication adherence, insurance access, and comorbidity management to reduce risk and improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.